Questcor - Best Pharma Stocks on 2007

Company: Questcor
Starting stock price: $1.45
Ending stock price: $5.77
Percent Change: 298%

Details: Union City, CA-based Questcor Pharmaceuticals develops and commercializes novel CNS-focused therapeutics. With 70 workers and a market cap of $366 million, the company's stock increased an impressive 298% in 2007. It's marketed products include Doral for insomnia and H.P. Acthar Gel.

Questcor - Best Pharma Stocks on 2007

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Novo Nordisk is betting big on GLP-1 Saxenda in its global obesity push, but England's cost watchdog is unimpressed with the drug's long-term outlook.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.